ENDURANT CAPITAL MANAGEMENT LP – Neurocrine Biosciences, Inc. Transaction History
ENDURANT CAPITAL MANAGEMENT LP portfolio value:
$0
portfolio value
ENDURANT CAPITAL MANAGEMENT LP quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -27.99K shares | -2.72M | $106.21 | 0 |
| Q2 2022 | share | Increase | 0.00% | 27.99K shares | 2.72M | $97.48 | 27.99K |
| Q1 2017 | share | Decrease | -100.00% | -11.5K shares | -445K | $43.3 | 0 |
| Q4 2016 | share | Decrease | -5.74% | -700 shares | -173K | $38.7 | 11.5K |
| Q3 2016 | share | Decrease | -13.48% | -1.9K shares | -23K | $50.64 | 12.2K |
| Q2 2016 | share | Increase | +7.63% | 1K shares | 123K | $45.45 | 14.1K |
| Q1 2016 | share | Increase | 0.00% | 13.1K shares | 518K | $39.55 | 13.1K |